ÃÜÌÒAV at MD&M West 2024 trade fair
New ÃÜÌÒAV medical polycarbonate pushes the boundaries of heat resistance
- Combines biocompatibility, heat-resistance, transparency and durability
- Boosts productivity in silicone overmolding applications
- Can contribute to customer sustainability goals
Overmolding polycarbonate with liquid silicone rubber (LSR) is commonly used to produce respiratory masks and other medical devices requiring molded-in seals. Now, ÃÜÌÒAV, a leading producer of advanced polymers and high-performance plastics has developed ¨C a copolycarbonate with the highest heat resistance ¨C enabling molders and medical OEMs to significantly slash production time and cost, without sacrificing quality, performance or appearance.
"We work closely with our healthcare customers and recognized that we could offer a polycarbonate made for highest curing temperatures in silicone over-molding, helping them more than double production volumes in the same amount of time due to shorter cycle times," said Pierre Moulinie, Global Healthcare Technology Lead, ÃÜÌÒAV LLC.
"Our experts provide support every step of the way," he continued, ¡°helping our customers calculate possible savings when switching to this new high-heat Apec? copolycarbonate grade ¨C for example, simulating material performance in specific applications and calculating cost benefits with our LSR calculator tool.¡±
In addition to offering high heat resistance and high productivity, Apec? 2045 copolycarbonate offers other important benefits for this market. These include:
- Durability: Tough engineering plastic with the highest heat resistance in the medical polycarbonate portfolio
- Transparency: Produces transparent parts with high optical clarity
- Biocompatible: Biocompatibility testing according to ISO 10993-1 and USP Class VI for contact of 30 days or less
- Sterilizable: Supports sterilization methods most prevalent in the healthcare industry, including irradiation, autoclave and hot air
- Processability: Consistent and efficient processing
Furthermore, using this new material may contribute to customer sustainability goals, as it can enable circular business models by supporting close- and open-loop recycling, as well as the possibility of attributed bio-circular content.
Attendees at , February 6-8 in Anaheim, California, can visit the ÃÜÌÒAV booth (#2221) to learn how the company¡¯s materials push boundaries in healthcare applications.
Polycarbonates from ÃÜÌÒAV are found in some of modern technology¡¯s most essential medical devices and play a major role in developing next-generation, life-saving technology. Used in applications where strength, clarity and toughness are necessary, polycarbonates from ÃÜÌÒAV exemplify the innovation, safety and biocompatibility that healthcare and life sciences designers and manufacturers across the world have come to know and trust. To learn more about how your company can use ÃÜÌÒAV¡¯s material expertise to enhance your medical and healthcare manufacturing, visit our .
About ÃÜÌÒAV:
ÃÜÌÒAV is one of the world¡¯s leading manufacturers of high-quality polymer materials and their components. With its innovative products, processes and methods, the company helps enhance sustainability and the quality of life in many areas. ÃÜÌÒAV supplies customers around the world in key industries such as mobility, building and living, as well as the electrical and electronics sector. In addition, polymers from ÃÜÌÒAV are also used in sectors such as sports and leisure, telecommunications and health, as well as in the chemical industry itself.
The company is geared completely to the circular economy. In addition, ÃÜÌÒAV aims to achieve climate neutrality for its Scope 1 and Scope 2 emissions by 2035, and the Group¡¯s Scope 3 emissions are also set to be climate neutral by 2050. ÃÜÌÒAV generated sales of EUR 14.2 billion in fiscal year 2024. At the end of 2024, the company had 46 production sites worldwide and employed approximately 17,500 people (calculated as full-time equivalents).
Forward-Looking Statements
This news release may contain forward-looking statements based on current assumptions and forecasts made by ÃÜÌÒAV. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in ÃÜÌÒAV¡¯s public reports which are available at www.covestro.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.